• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Alpha-galactosidase gene mutations in Fabry disease: heterogeneous expressions of mutant enzyme proteins.

作者信息

Okumiya T, Ishii S, Kase R, Kamei S, Sakuraba H, Suzuki Y

机构信息

Department of Clinical Genetics, Tokyo Metropolitan Institute of Medical Science, Japan.

出版信息

Hum Genet. 1995 May;95(5):557-61. doi: 10.1007/BF00223869.

DOI:10.1007/BF00223869
PMID:7759078
Abstract

Five point mutations were identified in unrelated Japanese Fabry disease hemizygotes: three new missense mutations, C142Y (425 G-->A), A156V (467 C-->T), and L166V (496 C-->G) in exon 3; one new splice site mutation at the 3' end of the consensus sequence in exon 4; one previously reported nonsense mutation, W44X (131 G-->A). C142Y expressed 50% of the normal enzyme protein in COS-1 cells, but catalytic activity was not detected. Both A156V and L166V expressed significant amounts of residual enzyme activity (6.7% and 9.8%) and enzyme proteins (10% each), the latter were more thermolabile at neutral pH than at acid pH, in vitro.

摘要

相似文献

1
Alpha-galactosidase gene mutations in Fabry disease: heterogeneous expressions of mutant enzyme proteins.
Hum Genet. 1995 May;95(5):557-61. doi: 10.1007/BF00223869.
2
Mutant alpha-galactosidase A enzymes identified in Fabry disease patients with residual enzyme activity: biochemical characterization and restoration of normal intracellular processing by 1-deoxygalactonojirimycin.在具有残余酶活性的法布里病患者中鉴定出的突变α-半乳糖苷酶A酶:生化特性及1-脱氧半乳糖野尻霉素对正常细胞内加工的恢复作用
Biochem J. 2007 Sep 1;406(2):285-95. doi: 10.1042/BJ20070479.
3
Galactose stabilizes various missense mutants of alpha-galactosidase in Fabry disease.半乳糖可稳定法布里病中α-半乳糖苷酶的各种错义突变体。
Biochem Biophys Res Commun. 1995 Sep 25;214(3):1219-24. doi: 10.1006/bbrc.1995.2416.
4
Fabry disease: characterization of alpha-galactosidase A double mutations and the D313Y plasma enzyme pseudodeficiency allele.法布里病:α-半乳糖苷酶A双重突变及D313Y血浆酶假性缺陷等位基因的特征
Hum Mutat. 2003 Dec;22(6):486-92. doi: 10.1002/humu.10275.
5
Nature and frequency of mutations in the alpha-galactosidase A gene that cause Fabry disease.导致法布里病的α-半乳糖苷酶A基因突变的性质和频率。
Am J Hum Genet. 1993 Dec;53(6):1186-97.
6
Identification of a novel point mutation (S65T) in alpha-galactosidase A gene in Chinese patients with Fabry disease. Mutations in brief no. 169. Online.中国法布里病患者α-半乳糖苷酶A基因新的点突变(S65T)的鉴定。简短突变报道第169号。在线发表。
Hum Mutat. 1998;11(4):328-30. doi: 10.1002/(SICI)1098-1004(1998)11:4<328::AID-HUMU11>3.0.CO;2-N.
7
A nonsense mutation (R220X) in the alpha-galactosidase A gene detected in a female carrier of Fabry disease.
Hum Mol Genet. 1994 Jun;3(6):1019-20. doi: 10.1093/hmg/3.6.1019.
8
Characterization of a mutant alpha-galactosidase gene product for the late-onset cardiac form of Fabry disease.法布里病迟发性心脏型突变α-半乳糖苷酶基因产物的特征分析
Biochem Biophys Res Commun. 1993 Dec 30;197(3):1585-9. doi: 10.1006/bbrc.1993.2659.
9
Fabry disease: identification of 50 novel alpha-galactosidase A mutations causing the classic phenotype and three-dimensional structural analysis of 29 missense mutations.法布里病:50个导致典型表型的新型α-半乳糖苷酶A突变的鉴定及29个错义突变的三维结构分析
Hum Genomics. 2006 Mar;2(5):297-309. doi: 10.1186/1479-7364-2-5-297.
10
Two novel mutations in the alpha-galactosidase gene in Japanese classical hemizygotes with Fabry disease.
Jpn J Hum Genet. 1996 Sep;41(3):313-21. doi: 10.1007/BF01913174.

引用本文的文献

1
Fabry disease: GLA deletion alters a canonical splice site in a family with neuropsychiatric manifestations.法布里病:GLA 缺失改变了具有神经精神表现的一家系中的一个典型剪接位点。
Metab Brain Dis. 2021 Feb;36(2):265-272. doi: 10.1007/s11011-020-00640-0. Epub 2020 Nov 6.
2
Misfolding of Lysosomal α-Galactosidase a in a Fly Model and Its Alleviation by the Pharmacological Chaperone Migalastat.溶酶体α-半乳糖苷酶 a 在果蝇模型中的错误折叠及其被药物伴侣米加司他缓解。
Int J Mol Sci. 2020 Oct 7;21(19):7397. doi: 10.3390/ijms21197397.
3
Functional evaluation of a novel GLA causative mutation in Fabry disease.

本文引用的文献

1
Quantitative analysis of dystrophin gene amplification products using a PC-based image analysis system.使用基于个人计算机的图像分析系统对肌营养不良蛋白基因扩增产物进行定量分析。
Int J Biomed Comput. 1993 Nov;33(3-4):277-86. doi: 10.1016/0020-7101(93)90041-4.
2
Human alpha-galactosidase gene expression: significance of two peptide regions encoded by exons 1-2 and 6.
Biochim Biophys Acta. 1994 Feb 16;1204(2):265-70. doi: 10.1016/0167-4838(94)90017-5.
3
Characterization of a mutant alpha-galactosidase gene product for the late-onset cardiac form of Fabry disease.法布里病迟发性心脏型突变α-半乳糖苷酶基因产物的特征分析
新型 GLA 致病突变致 Fabry 病的功能评估。
Mol Genet Genomic Med. 2019 Sep;7(9):e864. doi: 10.1002/mgg3.864. Epub 2019 Jul 18.
4
Plasma mutant α-galactosidase A protein and globotriaosylsphingosine level in Fabry disease.法布里病患者血浆中突变α-半乳糖苷酶A蛋白和球三糖神经酰胺水平
Mol Genet Metab Rep. 2014 Aug 2;1:288-298. doi: 10.1016/j.ymgmr.2014.07.005. eCollection 2014.
5
The alpha-galactosidase A p.Arg118Cys variant does not cause a Fabry disease phenotype: data from individual patients and family studies.α-半乳糖苷酶A p.Arg118Cys变异体不会导致法布里病表型:来自个体患者和家系研究的数据。
Mol Genet Metab. 2015 Feb;114(2):248-58. doi: 10.1016/j.ymgme.2014.11.004. Epub 2014 Nov 9.
6
De novo mutation in a male patient with Fabry disease: a case report.一名法布里病男性患者的新发突变:病例报告
BMC Res Notes. 2014 Jan 7;7:11. doi: 10.1186/1756-0500-7-11.
7
Development of a highly sensitive immuno-PCR assay for the measurement of α-galactosidase A protein levels in serum and plasma.开发一种高度敏感的免疫-PCR 测定法,用于测量血清和血浆中的α-半乳糖苷酶 A 蛋白水平。
PLoS One. 2013 Nov 13;8(11):e78588. doi: 10.1371/journal.pone.0078588. eCollection 2013.
8
Evaluation of N-nonyl-deoxygalactonojirimycin as a pharmacological chaperone for human GM1 gangliosidosis leads to identification of a feline model suitable for testing enzyme enhancement therapy.评价 N-正壬基去氧半乳糖基辛可宁碱作为人 GM1 神经节苷脂贮积病的药理学伴侣分子导致适合用于检测酶增强治疗的猫模型的鉴定。
Mol Genet Metab. 2012 Sep;107(1-2):203-12. doi: 10.1016/j.ymgme.2012.06.007. Epub 2012 Jun 19.
9
The molecular basis of pharmacological chaperoning in human α-galactosidase.人类α-半乳糖苷酶药理伴侣作用的分子基础。
Chem Biol. 2011 Dec 23;18(12):1521-6. doi: 10.1016/j.chembiol.2011.10.012.
10
Synergy between the pharmacological chaperone 1-deoxygalactonojirimycin and the human recombinant alpha-galactosidase A in cultured fibroblasts from patients with Fabry disease.1-脱氧野尻霉素与重组人α-半乳糖苷酶 A 在法布里病患者培养成纤维细胞中的协同作用。
J Inherit Metab Dis. 2012 May;35(3):513-20. doi: 10.1007/s10545-011-9424-3. Epub 2011 Dec 21.
Biochem Biophys Res Commun. 1993 Dec 30;197(3):1585-9. doi: 10.1006/bbrc.1993.2659.
4
Nature and frequency of mutations in the alpha-galactosidase A gene that cause Fabry disease.导致法布里病的α-半乳糖苷酶A基因突变的性质和频率。
Am J Hum Genet. 1993 Dec;53(6):1186-97.
5
A strategy to reveal high-frequency RFLPs along the human X chromosome.一种揭示人类X染色体上高频限制性片段长度多态性的策略。
Am J Hum Genet. 1984 May;36(3):546-64.
6
Human alpha-galactosidase A: nucleotide sequence of a cDNA clone encoding the mature enzyme.人α-半乳糖苷酶A:编码成熟酶的cDNA克隆的核苷酸序列
Proc Natl Acad Sci U S A. 1986 Jul;83(13):4859-63. doi: 10.1073/pnas.83.13.4859.
7
Fabry disease: isolation of a cDNA clone encoding human alpha-galactosidase A.法布里病:编码人α-半乳糖苷酶A的cDNA克隆的分离
Proc Natl Acad Sci U S A. 1985 Nov;82(21):7364-8. doi: 10.1073/pnas.82.21.7364.
8
Nucleotide sequence of the human alpha-galactosidase A gene.人类α-半乳糖苷酶A基因的核苷酸序列。
Nucleic Acids Res. 1989 Apr 25;17(8):3301-2. doi: 10.1093/nar/17.8.3301.
9
Fabry disease: six gene rearrangements and an exonic point mutation in the alpha-galactosidase gene.法布里病:α-半乳糖苷酶基因的六种基因重排和一个外显子点突变
J Clin Invest. 1989 Apr;83(4):1390-9. doi: 10.1172/JCI114027.
10
Identification of point mutations in the alpha-galactosidase A gene in classical and atypical hemizygotes with Fabry disease.法布里病经典型和非典型半合子中α-半乳糖苷酶A基因突变的鉴定。
Am J Hum Genet. 1990 Nov;47(5):784-9.